Call to Action: Comment on the FDA’s Rollback of Food Labeling During the Pandemic
By Jennifer Iscol On May 22, the U.S. Food and Drug Administration announced new guidance adding temporary flexibility to food labeling requirements to help minimize the impact of COVID-19 disruptions to the supply chain. We understand the necessity for the guidance and support it, but we are concerned that the guidance, as it is written, could confuse manufacturers and pose risks to consumers who are on a medically-prescribed gluten-free diet. The guidance temporarily allows manufacturers to make certain minor ingredient substitutions without relabeling their products. While it contains some safeguards to prevent gluten and common allergens from being used...
Read More
